ZYME Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
256.5M
+5487.4%
4.6M
+90.6%
2.4M
-4.3%
2.5M
-90.9%
27.6M
Cost of Revenue
0
0
0
0
0
Gross Profit
256.5M
+5487.4%
4.6M
+90.6%
2.4M
-4.3%
2.5M
-90.9%
27.6M
Operating Expenses
78.9M
+68.6%
46.8M
-5.6%
49.5M
+6.1%
46.7M
-6.1%
49.7M
R&D
36.1M
+31.7%
27.4M
-20.4%
34.5M
+10.3%
31.2M
-12.2%
35.6M
SG&A
42.7M
+121.0%
19.3M
+28.3%
15.1M
-2.4%
15.4M
+9.1%
14.1M
Operating Income
177.6M
+521.0%
-42180000
+10.5%
-47118000
-6.7%
-44152000
-99.7%
-22110000
EBITDA
179.3M
+536.9%
-41047000
+10.7%
-45979000
-6.8%
-43069000
-109.5%
-20557000
Net Income
173.7M
+485.8%
-45019000
-1.9%
-44162000
-7.2%
-41209000
-110.2%
-19602000
EPS (Basic)
$2.43
+491.9%
$-0.62
-5.1%
$-0.59
-7.3%
$-0.55
-111.5%
$-0.26
EPS (Diluted)
$2.28
+467.7%
$-0.62
-5.1%
$-0.59
-5.4%
$-0.56
-115.4%
$-0.26
Shares (Diluted)
76.3M
+4.5%
73.0M
-2.3%
74.7M
+1.9%
73.3M
-3.3%
75.8M
Zymeworks (ZYME) — Financials